Chhattisgarh HC: Complaints Without Disciplinary Action Cannot Affect a Judge's Seniority  ||  Delhi HC Upholds Selection of India's Dressage Team For the 2026 Asian Games  ||  MP High Court Orders State to Airlift Gas Pipeline Blast Victim to Ahmedabad For Treatment  ||  Delhi HC: Memorandum of Past Oral Family Settlement Needs No Registration if No New Rights Arise  ||  Chhattisgarh HC: Denying Marriage in Live-In Relationship Does Not Constitute Rape  ||  Madhya Pradesh High Court: BSF Must Assess Criminal Charge Gravity Before Declaring Candidate Unfit  ||  Bihar Tender Scam: Patna High Court Bars Media From Calling Accused 'Scamster' Before Trial  ||  Gujarat HC Terms Plea ‘Wholly Misconceived’ and Imposes Rs. 2 Lakh Cost over ASI Somnath Survey  ||  Gauhati HC Differs on Whether ED’s ‘Reason To Believe’ For Property Attachment is Confidential  ||  MP High Court Grants Bail To Tehelka Journalist, Noting Implication After Exposing Foeticide Racket    

Finalization of Draft Rules on Sale of Drugs by E-Pharmacies- (Press Information Bureau) (25 Jun 2019)

MANU/PIBU/0667/2019

Law of Medicine

The Government has published draft rules vide G.S.R. 817 (E) dated 28th August 2018 for inviting public/stakeholder comments for amendment to the Drugs and Cosmetics Rules, 1945 for incorporating provisions relating to regulation of sale and distribution of drugs through e-pharmacy. A large number of suggestions/comments have been received from the stakeholders, which are being examined. At the same time, the matter is sub-judice before various Hon'ble High Courts in the country. Therefore, no timeline for finalization of the rules can be provided.

Under the Drugs & Cosmetics Act and Rules, sale of spurious drugs is a punishable offence and State Licensing Authorities are empowered to take action in this regard. Accordingly, the complaints as received, are referred to State Licensing Authorities for taking action as per the provisions of the Act and Rules.

Tags : DRAFT RULES   FINALIZATION   SALE OF DRUGS   E-PHARMACIES  

Share :        

Disclaimer | Copyright 2026 - All Rights Reserved